Combined Modality TherapyMechlorethamineProcarbazineHodgkin DiseaseLomustineAntineoplastic Combined Chemotherapy ProtocolsVincristineRadiotherapyRadiotherapy DosagePrednisoneActuarial AnalysisCarcinoma, Small CellLung NeoplasmsRadiotherapy, AdjuvantCyclophosphamideToxicity TestsNeoplasm StagingSurvival AnalysisDoxorubicinCisplatinTreatment OutcomePrognosisFluorouracilSurvival RateChemotherapy, AdjuvantDisease-Free SurvivalClinical Trials as TopicAdenocarcinomaCarcinoma, Non-Small-Cell LungFollow-Up StudiesToxicity Tests, AcuteDose-Response Relationship, DrugLethal Dose 50Antineoplastic AgentsToxicity Tests, ChronicDrug Administration ScheduleTime FactorsNeoplasmsDiagnostic ImagingInfusions, IntravenousCell SurvivalMagnetic Resonance ImagingTomography, X-Ray ComputedNo-Observed-Adverse-Effect LevelMaximum Tolerated DoseAdministration, OralRadiation InjuriesRetrospective StudiesDrug EvaluationAntimetabolites, AntineoplasticDeoxycytidineLeukopeniaAntineoplastic Agents, PhytogenicToxicologyDrug-Related Side Effects and Adverse ReactionsPaclitaxelLiverPositron-Emission TomographyDrug-Induced Liver InjuryNeutropeniaCamptothecinCell Line, TumorNeoplasm Recurrence, LocalToxicity Tests, SubchronicAntidotesBreast NeoplasmsCarboplatinProspective StudiesSensitivity and Specificity